Cavitation Technologies CVAT

Cavitation Technologies Q3 FY26: revenue $3K, down 98%; diluted EPS $0.00

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Cavitation Technologies reported for Q3 FY26, the quarter ended Mar 31, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$3K−98% from $122K in Q3 FY2510-Q income statement, on EDGAR
  2. Net income−$219KAgainst −$230K in Q3 FY2510-Q income statement, on EDGAR
  3. Diluted EPS$0.00Against $0.00 in Q3 FY2510-Q income statement, on EDGAR
  4. Cash and cash equivalents$45K−90% from $432K in Q3 FY2510-Q balance sheet, on EDGAR
  5. Cash from operations−$126KAgainst −$248K in Q3 FY2510-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

Get an email when Cavitation Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 700 and related industry codes: the same peer list as the financial tables.